Skip to main content
. 2022 Jan 17;355(5):2100382. doi: 10.1002/ardp.202100382

Table 1.

Involvement of drugs in various stages of COVID‐19 viral infection

(a) (i) Hydroxychloroquine (a) In the viral entry inhibition of the host cell
(ii) Chloroquine
(iii) Mefloquine
(b) (i) Lopinavir (b) In the inhibition of viral replication
(ii) Ritonavir
(iii) Camostat
(iv) Ivermectin
(c) (i) Tipranavir (c) In the inhibition of 3C‐like protease
(d) (i) Remdesivir (d) In the inhibition of viral RNA synthesis by inhibiting the activity of RNA polymerase
(ii) Favipiravir